A E van Leeuwen-Stok, PhD
BOOG Study Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name A E van Leeuwen-Stok, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:43 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03820063 · Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 StudyBorstkanker Onderzoek Groep · active not recruiting · Breast Cancer
- Ph3NCT03425838 · Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast CancerBorstkanker Onderzoek Groep · active not recruiting · Breast Neoplasm Female · study director
- Ph2NCT03283384 · Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.Borstkanker Onderzoek Groep · active not recruiting · Breast Neoplasms · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 65 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.